News

ProKidney Corp. (PROK) shares just saw a massive green day. Results from Phase 2 were compelling and the data sharply ...
The Beach Boys are back in the top 40 for the first time in over a decade after the recent death of the band’s co-founder Brian Wilson. Billboard reports that the band’s greatest hits album, “Songs of ...
FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with CKD and type 2 diabetesFDA also confirmed that the ongoing Phase 3 PROACT 1 ...
New research reveals how serum soluble Klotho levels relate to chronic kidney disease risk (CKD) in patients with diabetes and hypertension.
Too often, patients with chronic kidney disease get diagnosed too late – if at all. Addressing risk factors early can stave off the disease’s worst effects.
Efficacy of febuxostat on hyperuricemia and estimated glomerular filtration rate in patients with non-dialysis stage 3/4 chronic kidney disease and assessment of cardiac function: a 12-month ...
In a 2024 clinical practice guideline issued by the Kidney Disease: Improving Global Outcomes organization, updated recommendations are presented for the evaluation, management, and treatment of ...
Updated chronic kidney disease guidelines recommended including cystatin C with creatinine to estimate glomerular filtration rate. Point-of-care-testing for creatinine and urine albumin ...
The Kidney Disease: Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney disease (CKD) management.
Women at any CKD stage may face complex pregnancy-related decisions and increased risks that are not adequately addressed by current guidelines.
The FDA has approved a new indication for semaglutide 1 mg to reduce the risk for worsening kidney disease, kidney failure and CV death among adults with type 2 diabetes and CKD.